Zolmitriptan for acute migraine attacks in adults
Author:
Affiliation:
1. University of Oxford; Lincoln College; Oxford UK
2. Oxford Oxfordshire UK
3. Plymouth UK
Publisher
Wiley
Subject
Pharmacology (medical)
Reference87 articles.
1. Astra Zeneca A multicentre, randomised, double-blind trial to compare the efficacy and safety of ZOMIG 2.5 mg, NARAMIG 2.5 mg and placebo in the acute treatment of adult patients with migraine www.astrazenecaclinicaltrials.com 2005
2. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet;Charlesworth;CNS Drugs,2003
3. Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study;Dahlöf;Eurean Journal of Neurology,1998
4. Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial;Dib;Neurology,2002
5. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study;Dodick;CNS Drugs,2005
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans;Handbook of Clinical Neurology;2024
2. Approach to headache disorders and the management of migraine: consensus guidelines from the Headache Society of Singapore, first edition (2023);Singapore Medical Journal;2023-09-19
3. Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis;The Journal of Headache and Pain;2023-09-18
4. Efficacy of zolmitriptan nasal spray in adult patients with migraine;Meditsinskiy sovet = Medical Council;2023-08-18
5. Zavegepant for the acute treatment of migraine: look before leaping;Nature Reviews Neurology;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3